Folgen
Martin Fellermeyer
Martin Fellermeyer
Postdoctoral scientist, University of Oxford
Bestätigte E-Mail-Adresse bei rdm.ox.ac.uk
Titel
Zitiert von
Zitiert von
Jahr
The bromodomain inhibitor JQ1 triggers growth arrest and apoptosis in testicular germ cell tumours in vitro and in vivo
S Jostes, D Nettersheim, M Fellermeyer, S Schneider, F Hafezi, ...
Journal of cellular and molecular medicine 21 (7), 1300-1314, 2017
902017
SOX2 is essential for in vivo reprogramming of seminoma-like TCam-2 cells to an embryonal carcinoma-like fate
D Nettersheim, A Heimsoeth, S Jostes, S Schneider, M Fellermeyer, ...
Oncotarget 7 (30), 47095, 2016
512016
Unique and redundant roles of SOX2 and SOX17 in regulating the germ cell tumor fate
SV Jostes, M Fellermeyer, L Arévalo, GE Merges, G Kristiansen, ...
International journal of cancer 146 (6), 1592-1605, 2020
362020
LARP1 isoform expression in human cancer cell lines
H Schwenzer, M Abdel Mouti, P Neubert, J Morris, J Stockton, S Bonham, ...
RNA biology 18 (2), 237-247, 2021
122021
The current state and future of T-cell exhaustion research
E Jenkins, T Whitehead, M Fellermeyer, SJ Davis, S Sharma
Oxford Open Immunology 4 (1), iqad006, 2023
102023
Antibody agonists trigger immune receptor signaling through local exclusion of receptor-type protein tyrosine phosphatases
AH Lippert, C Paluch, M Gaglioni, MT Vuong, J McColl, E Jenkins, ...
Immunity 57 (2), 256-270. e10, 2024
22024
The paralogues MAGOH and MAGOHB are oncogenic factors in high-grade gliomas and safeguard the splicing of cell division and cell cycle genes
RAS Barreiro, GDA Guardia, FM Meliso, X Lei, WQ Li, A Savio, ...
RNA biology 20 (1), 311-322, 2023
22023
Combination CD200R/PD-1 blockade in a humanised mouse model
M Fellermeyer, C Anzilotti, C Paluch, RJ Cornall, SJ Davis, U Gileadi
Immunotherapy Advances 3 (1), ltad006, 2023
22023
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–8